Peripheral Arterial Disease: Objectives. Disclosure. Definition: Peripheral Arterial Disease (PAD)
|
|
- Margaret Randall
- 5 years ago
- Views:
Transcription
1 Geriatric Grand Rounds Tuesday, April 21, :00 noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this event have been asked to disclose to the audience any involvement with industry or other organizations that may potentially influence the presentation of the educational material. Disclosure will be done both verbally and using a slide or handout. Peripheral Arterial Disease: Glenrose Hospital Rounds April 21, 2009 Visit web sites: for handouts, poster, schedule, subscription: for on-demand archive of previous presentations: Disclosure Sean McMurtry has no conflicts to declare Objectives Peripheral Arterial Disease What is it? How does it present? How is it diagnosed? What are its implications? How is it treated? Definition: Peripheral Arterial Disease (PAD) Diseases of the aorta and noncoronary branch arteries that are: Stenotic Occlusive Aneurysmal Generally atherosclerotic & thromboembolic Most PAD is lower extremity atherosclerosis peripheral vascular disease is an antiquated term You see a 84 year old female with exertional leg fatigue Bilateral leg fatigue when she walks (~1 block), but no pain Better with rest PMH Hypertension TC 7.1 HDL 1.3 LDL 4.9 Exsmoker Does she have PAD? Geriatric Grand Rounds, Glenrose Rehabilitation Hospital, Edmonton, AB, Canada April 21, 2009 Page 1 of 11
2 PAD: Claudication PAD: Presentations Classic Rose intermittent claudication: exertional calf pain does not begin at rest resolves within 10 minutes of rest Atypical leg pain: Exertional leg discomfort not meeting above criteria Atypical leg symptoms ~50% Classic claudication ~10% Asymptomatic ~40% AHA Heart Disease and Stroke Statistics Update. Ankle-Brachial Index (ABI) Sens ~95% Spec ~99% Hiatt Wr. N Engl J Med, 344(21): Automated BP Cuffs Can Accurately Measure ABI Beckman et al. Hypertension, 2006;47: ABI: Expected Range of Values < 0.9 is diagnostic of PAD Intermittent Claudication Range 0.2 to 1.0, with mean 0.59±0.15 Ischemic Rest Pain Range 0 to 0.65, with mean 0.26±0.13 Impending Gangrene Mean 0.05±0.08 If an ischemic ulcer is present: Expect the ankle pressures to be < 50 mmhg (ABI<0.4) Caveat Be aware of the possibility for multiple diagnoses in the elderly Geriatric Grand Rounds, Glenrose Rehabilitation Hospital, Edmonton, AB, Canada April 21, 2009 Page 2 of 11
3 You see a 84 year old female with exertional leg fatigue You see a 80 year old male with exertional leg pain What if: Right leg ABI 0.72 Left leg ABI 0.82 ABI < 0.9 she has symptoms due to PAD Classic description for claudication burning pain in the calf muscles and thighs that is relieved with rest PMH Prior anterior MI, s/p PCI LAD Dyslipidemia, HTN Appropriate medical tx for CAD Does he have PAD? You see a 80 year old male with exertional leg pain What if: Right leg ABI 1.04 Left leg ABI 1.01 ABI is in normal range does this exclude PAD? The Exercise ABI ABIs before and after exercise increases sensitivity and measures functional capacity Standard protocol: Manual exercise at 2mph with 12% grade Measure ABI at baseline, post exercise, and in recovery Drop in ABI of >20% (< 0.9) considered significant positive in ~31% of cases You see a 80 year old male with exertional leg pain Rest ABI: - Right leg ABI Left leg ABI 1.08 Post Exercise ABI - Right leg ABI Left leg ABI 0.68 ABI drops with exercise he has symptomatic PAD You wonder Who is at risk for PAD, and is it common? Geriatric Grand Rounds, Glenrose Rehabilitation Hospital, Edmonton, AB, Canada April 21, 2009 Page 3 of 11
4 % Partners Study 6979 ambulatory patients (primary care) 70 or older, with smoking or diabetes, were screened with history and ankle brachial index (ABI). Total PAD PAD only PAD + CVD Hirsch AT et al. JAMA. 2001;286: Incidence ~30% PAD: pan-vascular atherosclerosis 12-25% of PAD patients have a significant carotid stenosis on US 60-80% of PAD patients have at least one significant coronary artery stenosis ~33% of CAD or CVD patients also have PAD Hirsch AT et al. J Am Coll Cardiol. 2006;47;1-192 ACC/AHA PAD Guidelines: Populations at risk for PAD Age <50, with diabetes and one other risk factor (smoking, dyslipidemia, hypertension) Age and smoking or diabetes Age 70+ Leg symptoms with exertion or ischemic rest pain Abnormal lower extremity pulse examination Known atherosclerotic coronary, carotid, or renal artery disease Hirsch AT et al. J Am Coll Cardiol. 2006;47;1-192 In your practice PAD will be common if you see Diabetics Smokers Elderly Patients with CAD or CVD Most PAD will be asymptomatic PAD if screening ABI is not performed, most disease will not be detected You see an asymptomatic 80 year old woman PAD (regardless of symptoms) has significant mortality Asymptomatic PMH No symptomatic vascular disease smoker, osteoporosis Otherwise well On fosamax and calcium BP 122/76 TC 4.1 HDL 1.2 LDL 2.6 Normal fasting glucose 1 brother with MI at 51 ABI < 0.9 bilaterally Geriatric Grand Rounds, Glenrose Rehabilitation Hospital, Edmonton, AB, Canada April 21, 2009 Page 4 of 11
5 PAD is associated with: Up to 60% increase in MI ~40% increase in stroke Annual mortality of 4-6% Patients with more severe disease are at higher risk: Annual mortality ~25% for patients with critical limb ischemia Hirsch AT et al. J Am Coll Cardiol. 2006;47;1-192 PAD: Prognosis PAD: Prognosis Reduced ABI is associated with loss of mobility McDermott et al. J Am Coll Cardiol Mar 24;53(12): You see an asymptomatic 80 year old woman You see a 79 year old diabetic male with a right foot ulcer ABI < 0.9 bilaterally ABI < 0.9 is diagnostic for PAD (coronary risk equivalent) - ECASA 81 mg daily - smoking cessation - statin (LDL < 1.8) - ACE-inhibitor She is at risk for loss of mobility DM II for 15 years HTN, mixed dyslipidemia, non-smoker No known vascular disease ABI in the office: Right ankle 1.5 Left ankle 1.4 ABI > 1.3 is calcification artifact (noncompressible vessels) Common in diabetics (~10%) Abnormal, but not diagnostic of PAD PAD: Critical Limb Ischemia Incidence: ~ per million per year Diagnostic Criteria are: >2 weeks of recurrent foot pain at rest or a non-healing wound or gangrene of the foot or toes AND an ankle pressure < 50 mmhg or toe pressure < 30 mmhg Toe Brachial Index (TBI) The toe-brachial index should be used when the ABI test is not reliable due to non-compressible vessels (ABI > 1.3) TBI <0.7 is diagnostic of PAD Usually vascular lab required Hirsch AT et al. J Am Coll Cardiol. 2006;47;1-192 Geriatric Grand Rounds, Glenrose Rehabilitation Hospital, Edmonton, AB, Canada April 21, 2009 Page 5 of 11
6 TBI: Expected Range of Values Intermittent Claudication mean 0.35±0.15 Ischemic Rest Pain or Gangrene mean 0.11±0.10 Note: the TBI is rarely falsely increased due to non-compressible vessels If an ischemic ulcer is present: Expect the Toe pressures to be < 30 mmhg (TBI<0.3) You see a 79 year old diabetic male with a foot ulcer TBI s performed at the vascular lab Right TBI 0.22 ( Toe pressure 28 mmhg) Left TBI 0.52 (Toe pressure 66 mmhg) The TBI is < 0.7 (PAD is present), and the right Toe pressure is < 30mmHg (consistent with ulceration and gangrene) Revascularization or amputation required! Your patient has a noninvasive arterial study what happens? 58 year old male with a bilateral claudication and left toe rest pain PMH Current smoker HTN, dyslipidemia, DM Erectile dysfunction A typical study Included: ABI TBI Segmental doppler pressures C-wave doppler waveforms Not included Pulse volume recording Exercise stress testing Segmental Doppler Pressures Imaging: C-Wave Doppler US 1 0 Triphasic C-Wave Doppler waveforms supplement segmental Doppler pressures Biphasic Monophasic Gerhard-Herman M et al. Vasc Med. 2006;11; Monophasic Geriatric Grand Rounds, Glenrose Rehabilitation Hospital, Edmonton, AB, Canada April 21, 2009 Page 6 of 11
7 Pulse Volume Morphology Example: Left Leg Critical Limb Ischemia Ankle pressures: 45mmHg ( < 50 mmhg consistent with CLI) ABI: 0.30 ( < 0.40 consistent with CLI) Gerhard-Herman M et al. Vasc Med. 2006;11; Important Point You will not get an exercise ABI unless you ask for one! Approach to leg pain NYD Vascular History and Physical Ankle brachial index <0.9 - PAD diagnosed >1.3 - vessels calcified Do toe brachial index» <0.7 - PAD diagnosed» PAD excluded» >1.1 vessels calcified, consider imaging test non-diagnostic ABI Do exercise ABI» Fall in ABI > 20% - PAD diagnosed» No Fall in ABI - PAD excluded You see a 82 year old man with PAD Bilateral claudication pain Screening ABI <0.9 both legs Co-morbidities Current smoker BP 150/88 HDL 1.1 LDL 3.8 TG 1.6 Normal fasting glucose How should he be treated? Prevent Amputation PAD Management CV Risk Reduction PAD Patient All Patients Symptomatic Patients Treat Claudication Geriatric Grand Rounds, Glenrose Rehabilitation Hospital, Edmonton, AB, Canada April 21, 2009 Page 7 of 11
8 CV Risk Reduction sensible diet regular exercise (30 minutes of walking 3/week) smoking cessation treat hypertension (< 140/90, < 130/80 for DM or CKD) ACE inhibitor treat lipids (target LDL at least < 2.0 mmol/l, if not <1.8) statin treat DM (target HgB A1C <7.0%) antiplatelet therapy CV Risk Reduction: Antiplatelet therapy antiplatelet BMJ. 2002;324: trials evaluated patients with MI, stroke, or symptomatic PAD randomized to clopidogrel 75mg vs. ASA 325mg daily for ~3 years No difference in safety Overall: 5.32% vs 5.83% (stroke, MI,Death, p<0.05) Symptomatic PAD: 3.71% vs. 4.83%, p<0.005 CV Risk Reduction: ASA vs. plavix Lancet. 1996;348: Dual antiplatelet therapy: Charisma trial patients with MI, stroke, symptomatic PAD or mutliple RFs randomized to clopidogrel+asa or ASA for ~3 years 6.8% vs 7.3% (stroke, MI,Death, p=.22) 1.7% vs 1.3% (severe bleeding, p=.09) Subgroup Analysis of symptomatic disease only: 6.9% vs 7.9%, (stroke, MI, CV death, p<0.05) NEJM. 2006;354: Dual antiplatelet therapy: Charisma trial redux Reach Registry 9478 patients with MI, stroke, symptomatic PAD included - randomized to clopidogrel+asa or ASA for ~28 months 7.3% vs 8.8% (stroke, MI,Death, p=.01) 1.7% vs 1.5% (severe bleeding, p=.5) 2.0% vs 1.3% (moderate bleeding, p=.004) JACC. 2007;49: Geriatric Grand Rounds, Glenrose Rehabilitation Hospital, Edmonton, AB, Canada April 21, 2009 Page 8 of 11
9 CV Risk Reduction: Statins 6748 of patients in HPS had symptomatic PAD Simvastatin 40mg vs placebo for 5 years Endpoint was vascular events (MI, stroke, revascularization) 22% RRR for simvastatin (6.3% ARR) CV Risk Reduction: Ace-Inhibitors 3099 patients with symptomatic PAD in HOPE, and ABI s measured Ramipril vs. Placebo for 4.5 years Endpoint: stroke, MI, CV death 13.1% for ramipril vs. 18.0% for placebo (ARR 4.9%) J Vasc Surg. 2007;45: Eur Heart J : PAD CV Risk Reduction Overview PAD Management Antiplatelet Minimum ECASA 81 mg daily Consider plavix or ASA+plavix in selected patients Statin ACE-inhibitor Other Antihypertensives for BP <140/90 (130/80) Oral hypoglycemics for HgBA1c < 7.0% Adjuvant therapy for smoking cessation Note: beta blockers are not contra-indicated Prevent Amputation CV Risk Reduction PAD Patient All Patients Symptomatic Patients Treat Claudication Standard prophylactic advice: foot care for PAD or DM PAD Management Avoid walking barefoot, or exposure to excess heat The toenails should be trimmed to the shape of the foot The feet should be inspected daily (a mirror or second person may be required) The feet should be washed daily with lukewarm water and mild soap, then dried well, followed by application of a moisturizing cream or lotion Socks should be worn, and shoes should fit well and be snug but not too tight Prevent Amputation CV Risk Reduction PAD Patient All Patients Symptomatic Patients Treat Claudication Geriatric Grand Rounds, Glenrose Rehabilitation Hospital, Edmonton, AB, Canada April 21, 2009 Page 9 of 11
10 Treatment of Claudication Cilostazol unavailable in Canada Supervised Exercise Rehabilitation is the main treatment Treatment of Claudication: Benefits of Exercise Rehab Vasc Med : Designing an exercise program Warm up and cool down of 5 minutes Treadmill or track exercises most effective Set initial workload to elicit symptoms in 3-5 minutes When moderate pain achieved, then rest (stand or sit) until pain relieved Repeat for a total of ~30 minutes, and gradually increase exercise time to ~50 minutes Exercise 3-5 times per week for 12 weeks Role of supervision is to ensure that workload is increased to the point of claudication Revascularization Usually reserved for critical limb ischemia Revascularization may be indicated for severe lifestyle limiting claudication despite non-invasive therapy For proximal (Aorto-iliac disease), angioplasty can be first line therapy Vasc Med : You see a 82 year old man with PAD you offer Medical therapy ECASA 81 mg daily Simvastatin 80 mg daily (LDL < 1.8) Ramipril 5 mg daily (BP < 140/80) 12 weeks of Varenicline 1mg bid Advice regarding daily foot care Advice regarding heart healthy diet Exercise program Suggestions for referral Vascular Physician To clarify the diagnosis Expedite exercise testing Coordinate Exercise rehabilitation for claudication CV risk reduction Pre-revascularization (Peri-operative) evaluation Vascular Surgeon or Interventional Radiologist Critical limb ischemia Severe claudication despite optimal non-invasive therapy Aorto-iliac disease Geriatric Grand Rounds, Glenrose Rehabilitation Hospital, Edmonton, AB, Canada April 21, 2009 Page 10 of 11
11 Questions? Sean McMurtry Tel: Fax: Geriatric Grand Rounds, Glenrose Rehabilitation Hospital, Edmonton, AB, Canada April 21, 2009 Page 11 of 11
Peripheral Arterial Disease Extremity
Peripheral Arterial Disease Lower Extremity 05 Contributor Dr Steven Chong Advisors Dr Ashish Anil Dr Tay Jam Chin Introduction Risk Factors Clinical Presentation Classification History PHYSICAL examination
More informationIntroduction to Peripheral Arterial Disease. Stacey Clegg, MD Interventional Cardiology August
Introduction to Peripheral Arterial Disease Stacey Clegg, MD Interventional Cardiology August 20 2014 Outline (and for the ABIM board exam * ** ***) Prevalence* Definitions Lower Extremity: Aorta*** Claudication***
More informationCase Study: Chris Arden. Peripheral Arterial Disease
Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she
More informationWhat s New in the Management of Peripheral Arterial Disease
What s New in the Management of Peripheral Arterial Disease Sibu P. Saha, MD, MBA Professor of Surgery Chairman, Directors Council Gill Heart Institute University of Kentucky Lexington, KY Disclosure My
More informationThe Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease
Interventional Cardiology and Cath Labs The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease Manesh R. Patel MD Chief,
More informationIntroduction. Risk factors of PVD 5/8/2017
PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental
More informationLarry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI
PAD Diagnosis Larry Diaz, MD, FSCAI Metro Health / University of Michigan Health, Wyoming, MI Mehdi H. Shishehbor, DO, FSCAI University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH PAD:
More informationPeripheral Artery Disease Role of Exercise, Endovascular and Surgical Options
Peripheral Artery Disease Role of Exercise, Endovascular and Surgical Options Jeffrey W. Olin, D.O., F.A.C.C., F.A.H.A. Professor of Medicine (Cardiology) Director of Vascular Medicine & the Vascular Diagnostic
More informationCurrent Vascular and Endovascular Management in Diabetic Vasculopathy
Current Vascular and Endovascular Management in Diabetic Vasculopathy Yang-Jin Park Associate professor Vascular Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine Peripheral artery
More informationImaging for Peripheral Vascular Disease
Imaging for Peripheral Vascular Disease James G. Jollis, MD Director, Rex Hospital Cardiovascular Imaging Imaging for Peripheral Vascular Disease 54 year old male with exertional calf pain in his right
More informationPractical Point in Diabetic Foot Care 3-4 July 2017
Diabetic Foot Ulcer : Role of Vascular Surgeon Practical Point in Diabetic Foot Care 3-4 July 2017 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai University
More informationPeripheral Arterial Disease. Westley Smith MD Vascular Fellow
Peripheral Arterial Disease Westley Smith MD Vascular Fellow Background (per 10,000) Goodney P, et al. Regional intensity of vascular care and lower extremity amputation rates. JVS. 2013; 6: 1471-1480.
More informationTreatment Strategies For Patients with Peripheral Artery Disease
Treatment Strategies For Patients with Peripheral Artery Disease Presented by Schuyler Jones, MD Duke University Medical Center & Duke Clinical Research Institute AHRQ Comparative Effectiveness Review
More informationPractical Point in Holistic Diabetic Foot Care 3 March 2016
Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai
More informationMedical Therapy for Peripheral Artery Disease
Medical Therapy for Peripheral Artery Disease Beau M. Hawkins, MD, FSCAI University of Oklahoma Health Sciences Center, Oklahoma City, OK Sahil A. Parikh, MD, FSCAI Columbia University Medical Center,
More informationA new era in the treatment of peripheral artery disease (PAD)?
A new era in the treatment of peripheral artery disease (PAD)? Prof. Dr. Jan Beyer-Westendorf Head of Thrombosis Research, University Hospital Carl Gustav Carus, TU Dresden; Germany Senior Lecturer Thrombosis
More informationGarland Green, MD Interventional Cardiologist. Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management
Garland Green, MD Interventional Cardiologist Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management Peripheral Arterial Disease Affects over 8 million Americans Affects 12% of the general
More informationTicagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease (EUCLID Trial)
Audience Interaction The chat box is available on the left hand side. Let us know who you are and where you re viewing from! Questions can be entered by hitting the green box with a question mark in it
More informationPerfusion Assessment in Chronic Wounds
Perfusion Assessment in Chronic Wounds American Society of Podiatric Surgeons Surgical Conference September 22, 2018 Michael Maier, DPM, FACCWS Cardiovascular Medicine Cleveland Clinic Disclosures Speaker,
More informationPeripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment
Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment Prepared and Presented by Jon Manocchio, Pharm D Blanchard Valley Hospital October 2011 Introduction PAD is a condition that is
More informationEarly Identification of PAD: Evidence to Refute USPSTF Position on Screening
Early Identification of PAD: Evidence to Refute USPSTF Position on Screening Mehdi H. Shishehbor, DO, MPH, PhD Director Endovascular Services Interventional Cardiology & Vascular Medicine Department of
More information7 th Munich Vascular Conference
7 th Munich Vascular Conference Secondary prevention of major cardiovascular events in patients with CHD or PAD - What can we learn from EUCLID and COMPASS, evaluating Clopidogrel, Ticagrelor and Univ.-Prof.
More informationPeripheral Arterial Disease: Screening, Evaluation and Management. Mitchel Sklar, MD, FACC, FSCAI. Cardiovascular Associates of R.I.
Peripheral Arterial Disease: Screening, Evaluation and Management Mitchel Sklar, MD, FACC, FSCAI Cardiovascular Associates of R.I. Natural History of Intermittent Claudication/PAD: Peripheral to what?
More informationDiagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC
Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton,
More informationRole of ABI in Detecting and Quantifying Peripheral Arterial Disease
Role of ABI in Detecting and Quantifying Peripheral Arterial Disease Difference in AAA size between US and Surgeon 2 1 0-1 -2-3 0 1 2 3 4 5 6 7 Mean AAA size between US and Surgeon Kathleen G. Raman MD,
More informationUSWR 23: Outcome Measure: Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential
USWR 23: Outcome Measure: Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential MEASURE STEWARD: The US Wound Registry [Note: This measure
More informationDapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58
Dapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58 Marc P. Bonaca MD MPH for the DECLARE TIMI 58 Investigators American College of Cardiology March 2019
More informationNational Clinical Conference 2018 Baltimore, MD
National Clinical Conference 2018 Baltimore, MD No relevant financial relationships to disclose Wound Care Referral The patient has been maximized from a vascular standpoint. She has no other options.
More informationSteven Hadesman, MD Chief Medical Officer, MeridianRx Internal Medicine Physician, St. John Hospital
Steven Hadesman, MD Chief Medical Officer, MeridianRx Internal Medicine Physician, St. John Hospital Deep Venous Thrombosis Varicose Veins Venous insufficiency Phlebitis Lymphedema Elephantiasis nostras
More informationClinical Approach to CLI and Related Diagnostics: What You Need to Know
Clinical Approach to CLI and Related Diagnostics: What You Need to Know Ido Weinberg, MD Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital None Disclosures Critical
More informationMedical Management of Vascular Disease KEITH E SWANSON MD ND ACADEMY OF FAMILY PHYSICIANS FAMILY MEDICINE UPDATE JANUARY 2017
Medical Management of Vascular Disease KEITH E SWANSON MD ND ACADEMY OF FAMILY PHYSICIANS FAMILY MEDICINE UPDATE JANUARY 2017 Objectives 1. Appreciate the long term implications of PAD 2. Appreciate the
More informationJoshua A. Beckman, MD. Brigham and Women s Hospital
Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham
More informationACC NY Cardiovascular Symposium
ACC NY Cardiovascular Symposium Peripheral Vascular Disease: Watch the Heart and the Brain Evolving Role of Exercise, ACE-Inhibitors, Interventional and Surgical Options Mark A. Creager, M.D President,
More informationPAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014
PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 Van Crisco, MD, FACC, FSCAI First Coast Heart and Vascular Center, PLLC Jacksonville, FL 678-313-6695 Conflict of Interest Bayer Healthcare
More informationGuidelines for Management of Peripheral Arterial Disease
Guidelines for Management of Peripheral Arterial Disease Subhash Banerjee, MD, FACC, FSCAI Professor of Medicine, Univ. of Texas Southwestern Medical Center Chief, Division of Cardiology, VA North Texas
More informationIs there enough evidence for DAPT after endovascular intervention for PAOD?
Is there enough evidence for DAPT after endovascular intervention for PAOD? Prof. I. Baumgartner Head Clinical & Interventional Angiology University Hospital Bern Disclosure Speaker name:...i. Baumgartner...
More informationPeripheral Arterial Disease Management A Practical Guide for Internists. EFIM Vascular Working Group
2 Peripheral Arterial Disease Management A Practical Guide for Internists EFIM Vascular Working Group 1 Peripheral arterial disease (PAD) is a growing concern among our aging population. More than 27 million
More informationThe Struggle to Manage Stroke, Aneurysm and PAD
The Struggle to Manage Stroke, Aneurysm and PAD In this article, Dr. Salvian examines the management of peripheral arterial disease, aortic aneurysmal disease and cerebrovascular disease from symptomatology
More informationMaximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia
Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia Traci A. Kimball, MD Department of Surgery Grand Rounds Septemember 13, 2010 Overview Defining Critical Limb Ischemia Epidemiology
More informationJohn E. Campbell, MD. Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division
John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,
More informationManagement of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018
Management of Stable Ischemic Heart Disease Vinay Madan MD February 10, 2018 1 Disclosure No financial disclosure. 2 Overview of SIHD Diagnosis Outline of talk Functional vs. Anatomic assessment Management
More informationCardiovascular Update for Primary Care Providers. Peripheral Vascular Disease October 4 th 2014 Roberto A. Corpus Jr., MD
Cardiovascular Update for Primary Care Providers Peripheral Vascular Disease October 4 th 2014 Roberto A. Corpus Jr., MD Agenda Lower Extremity pain Initial evaluation Treatment options of noncritical
More informationPeripheral Arterial Disease: Who has it and what to do about it?
Peripheral Arterial Disease: Who has it and what to do about it? Seth Krauss, M.D. Alaska Annual Nurse Practitioner Conference September 16, 2011 Scope of the Problem Incidence: 20%
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationSurveillance of Peripheral Arterial Disease Cases Using Natural Language Processing of Clinical Notes
Surveillance of Peripheral Arterial Disease Cases Using Natural Language Processing of Clinical Notes Naveed Afzal, Sunghwan Sohn, Christopher G. Scott, Hongfang Liu, Iftikhar J. Kullo, Adelaide M. Arruda-Olson
More informationIs there an association between atherosclerosis and chronic venous disease?
Is there an association between atherosclerosis and chronic venous disease? Karel Roztocil, IKEM, Praha Hungarian Society of Angiology and Vascular Surgery Congress, Szombathely 2017 Disclosure Nothing
More informationDisclosures. Critical Limb Ischemia. Vascular Testing in the CLI Patient. Vascular Testing in Critical Limb Ischemia UCSF Vascular Symposium
Disclosures Vascular Testing in the CLI Patient None 2015 UCSF Vascular Symposium Warren Gasper, MD Assistant Professor of Surgery UCSF Division of Vascular Surgery Critical Limb Ischemia Chronic Limb
More informationWhen to screen for PAD? Prof. Dr.Tine De Backer Prof. Dr. Jean-Claude Wautrecht
When to screen for PAD? Prof. Dr.Tine De Backer Prof. Dr. Jean-Claude Wautrecht How do we define asymptomatic PAD? A. ABI < 1 B. ABI < 0.9 C. ABI < 0.8 D. ABI > 1 How do we define asymptomatic PAD? A.
More informationHow Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia?
How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia? Ehrin J. Armstrong, MD MSc MAS Director, Interventional Cardiology Director, Vascular Laboratory VA Eastern Colorado Healthcare
More informationSTATINS FOR PAD Long - term prognosis
STATINS FOR PAD Long - term prognosis Prof. Pavel Poredos, MD, PhD Department of Vascular Disease University Medical Centre Ljubljana Slovenia DECLARATION OF CONFLICT OF INTEREST No conflict of interest
More informationLimb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017
Limb Salvage in Diabetic Ischemic Foot Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Case Male 67 years old Underlying DM, HTN, TVD Present with gangrene
More informationObjectives. Abdominal Aortic Aneuryms 11/16/2017. The Vascular Patient: Diagnosis and Conservative Treatment
The Vascular Patient: Diagnosis and Conservative Treatment Ferrell-Duncan Clinic Zachary C. Schmittling, M.D., F.A.C.S. Vascular and General Surgery Ferrell-Duncan Clinic Cox Health Systems Objectives
More informationClinico e Trattamento Post- Rivascolarizzazione Percutanea
Minicorso GISE: Interventistica per gli arti inferiori e per il piede diabetico Follow-up Clinico e Trattamento Post- Rivascolarizzazione Percutanea Giuseppe Biondi Zoccai Ospedale San Giovanni Battista
More informationGeriatric Grand Rounds. Geriatric Grand Rounds. Heart Disease in the Elderly: Pitfalls and Practicalities. Objectives. Conflict of Interest Disclosure
Geriatric Grand Rounds Tuesday, January 22, 2008 12:00 noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital To receive the poster, and handouts via email, subscribe to our E-mailing list at
More informationIntercepting PAD. Playbook for Cardiovascular Care 2018 February 24, Jonathan D Woody, MD, FACS. University Surgical Vascular
Intercepting PAD Playbook for Cardiovascular Care 2018 February 24, 2018 Jonathan D Woody, MD, FACS University Surgical Vascular Attending Vascular Surgeon - Piedmont Athens Regional Adjunct Clinical Associate
More information5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016
Outpatient Stroke Management Sheila Smith MD May 5, 2016 1 Management of Outpatient Stroke Objectives Review blood pressure management post stroke Review antithrombotic therapy Review statin therapy Discuss
More informationTABLE OF CONTENTS. 2. LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE 2.1. Epidemiology Risk Factors
LOWER EXTREMITY PAD The following is one of three extracted sections lower extremity, renal/mesenteric, and abdominal aortic of the ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationArterial Studies And The Diabetic Foot Patient
Arterial Studies And The Patient George L. Berdejo, BA, RVT, FSVU gberdejo@wphospital.org Disclosures I have nothing to disclose! Diabetes mellitus continues to grow in global prevalence and to consume
More informationEDUCATION. Peripheral Artery Disease
EDUCATION Peripheral Artery Disease Peripheral Artery Disease You may have circulation problems that have to do with your blood vessels. You may feel aches, pains, cramps, numbness or muscle fatigue when
More informationA Healthy Heart. IN BRIEF: Your Guide to
IN BRIEF: Your Guide to A Healthy Heart If you re like most people, you may think of heart disease as a problem for other folks. If you re a woman, you may believe that being female protects you from heart
More informationAntiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.
Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,
More informationDisclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?
Disclosures JUPITER: The final frontier in statin utilization or an idea from outer space? Kathy E. Komperda, PharmD, BCPS Midwestern University Chicago College of Pharmacy kkompe@midwestern.edu 4/25/09
More informationRadiologic Evaluation of Peripheral Arterial Disease
January 2003 Radiologic Evaluation of Peripheral Arterial Disease Grace Tye, Harvard Medical School Year III Patient D.M. CC: 44 y/o male with pain in his buttocks Occurs after walking 2 blocks. Pain is
More informationPeripheral Arterial Disease
UFS Peripheral Arterial Disease A problem of supply and demand Larry Rhoads, Associate Chief Underwriter November 8, 2011 PAD Two categories of these circulation disorders: Functional peripheral vascular
More informationΑντιθρομβωτική αγωγή σε ασθενείς με περιφερική αρτηριακή νόσο των κάτω άκρων
Αντιθρομβωτική αγωγή σε ασθενείς με περιφερική αρτηριακή νόσο των κάτω άκρων Μ. Ματσάγκας, MD, PhD, FEBVS Καθηγητής Αγγειοχειρουργικής Πανεπιστήμιο Θεσσαλίας Prevalence (millions) PAD Affects Millions
More informationPrevention of MACROvascular Complications of Diabetes
Prevention of MACROvascular Complications of Diabetes Matt Bouchonville, MD, CDE Endocrinology Division University of New Mexico School of Medicine July 12, 2018 Conflicts of Interest None Objectives 1.
More informationMaria Angela S. Cruz-Anacleto, MD
Maria Angela S. Cruz-Anacleto, MD 57/Female Menopausal Non-HTN, non-dm Hypothyroid (s/p RAI 1997) Levothyroxine 100 ug OD 5 Months PTA Chest discomfort Stress Echocardiography 5 Months PTA Chest discomfort
More informationCardiovascular Disease in CLI Patients
L E I P Z I G I N T E R V E N T I O N A L C O U R S E 2 0 1 8 Nurse and Technician Forum - Part II Cardiovascular Disease in CLI Patients Corneliu Popescu Universitätsklinikum Leipzig Disclosure Speaker
More informationLearning About. Peripheral Artery Disease
SM A C P S P E C I A L R E P O R T Learning About Peripheral Artery Disease What Is Peripheral Artery Disease? Peripheral artery disease (PAD) is a form of atherosclerosis the hardening and narrowing of
More informationOUTPATIENT DEPARTMENT
1 This chapter outlines the main arterial and venous diseases that are likely to be seen within a vascular outpatient setting. It also highlights the role of the vascular nurse specialist wherever appropriate.
More informationEvolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC)
Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC) W. Schuyler Jones, MD FACC Director, Adult Cardiac Catheterization Laboratory
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Peripheral arterial disease Potential output:
More informationNurse and Technician Forum Part II Critical Limb Ischemia: Optimal care, an interdisciplinary challenge
L E I P Z I G I N T E R V E N T I O N A L C O U R S E 2017 Nurse and Technician Forum Part II Critical Limb Ischemia: Optimal care, an interdisciplinary challenge Markus Haumer Landesklinikum Baden-Mödling
More informationNational Vascular Registry
National Vascular Registry Bypass Patient Details Patient Consent* 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s) or postcode.
More information03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE
CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE Elizabeth L. Detschelt, M.D. Allegheny Health Network Vascular and Endovascular Symposium April 2, 2016 DISCLOSURES I have no
More informationRichard Grocott Mason
Richard Grocott Mason What to do with a 50 year old man with chest pain? Does the pain sound cardiac? Is this a possible acute coronary syndrome? Does patient have a previous cardiac history? Natural history
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationLong-Term Complications of Diabetes Mellitus Macrovascular Complication
Long-Term Complications of Diabetes Mellitus Macrovascular Complication Sung Hee Choi MD, PhD Professor, Seoul National University College of Medicine, SNUBH, Bundang Hospital Diabetes = CVD equivalent
More informationBoca Raton Regional Hospital Grand Rounds September 13, 2016
Boca Raton Regional Hospital Grand Rounds September 13, 2016 W. Anthony Lee, MD, FACS Chief, BocaCare Vascular Surgery Christine E. Lynn Heart and Vascular Institute Boca Raton, Florida Disclosures No
More informationDue to Perimed s commitment to continuous improvement of our products, all specifications are subject to change without notice.
A summary Disclaimer The information contained in this document is intended to provide general information only. It is not intended to be, nor does it constitute, medical advice. Under no circumstances
More informationPeripheral Arterial Disease Medical Approach and Management
Peripheral Arterial Disease Medical Approach and Management April 2, 2016 Michael F. Hagerty, MD FACC PAD: Classic and New Concepts Let s take a look at what s new and what s old or classic in 2016. PAD:
More information3-year results of the OLIVE registry:
3-year results of the OLIVE registry: A prospective multicenter study in patients with critical limb ischemia Osamu Iida, MD Kansai Rosai Hospital Cardiovascular Center Amagasaki, Hyogo, Japan Disclosure
More informationMedical Therapy of Peripheral Artery Disease
Medical Therapy of Peripheral Artery Disease Alvaro Alonso, MD Assistant Professor of Medicine Associate Director, Interven4onal Cardiology Fellowship Program Tulane University Heart & Vascular Ins4tute
More informationUC SF. Disclosures. Vascular Assessment of the Diabetic Foot. What are the best predictors of wound healing? None. Non-Invasive Vascular Studies
Disclosures Vascular Assessment of the Diabetic Foot What are the best predictors of wound healing? None Shant Vartanian MD Assistant Professor of Vascular Surgery UCSF Vascular Symposium April 20, 2013
More informationCardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology
Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations
More informationDavid A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio
1 STABLE ISCHEMIC HEART DISEASE: A NON-INVASIVE CARDIOLOGIST S PERSECTIVE 2018 Cardiovascular Course for Trainees and Early Career Physicians APRIL 20, 2018 David A. Orsinelli, MD, FACC, FASE Professor,
More informationImaging Strategy For Claudication
Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon
More informationRevascularisation for Claudication: When is it indicated, when not? Markus Haumer Landesklinikum Baden-Mödling Austria
Revascularisation for Claudication: When is it indicated, when not? Markus Haumer Landesklinikum Baden-Mödling Austria Disclosure Disclosure Speaker name: Markus Haumer, MD I have the following potential
More informationGoals of Screening Programs. What is Vascular Screening? Assumptions Regarding the Potential Benefits of Screening Programs PAD
Conflict of Interest Disclosure (Relationships with Industry) An Epidemic of : The Debate Over Population Screening Membership on an advisory board, consultant, or recipient of a research grant from the
More informationEnvironmental. Vascular / Tissue. Metabolics
Global Risk Reduction--WINS Picking Mom and Dad-2016 Environmental Vascular / Tissue Metabolics Stop smoking-1b Physical activity-1b Weight control-1b Chelation therapy-3c Influenza vaccination-1b Blood
More informationWPCCS May2013. Mr Ian Williams Consultant Vascular Surgeon UHW. Consultant Cardiologist UHW
Peripheral Vascular Disease WPCCS May2013 Mr Ian Williams Consultant Vascular Surgeon UHW Prof Julian Halcox Prof Julian Halcox Consultant Cardiologist UHW Case 1? Ischaemic Legs History 85 years lady?varicose
More informationHybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case
Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case Chernyavskiy M.,MD,PhD, Chernova D., Zherdev N., Chernov A. Almazov National Medical Research Centre, St.Petersburg, Russia
More informationV.A. is a 62-year-old male who presents in referral
, LLC an HMP Communications Holdings Company Clinical Case Update Latest Trends in Critical Limb Ischemia Imaging Amit Srivastava, MD, FACC, FABVM Interventional Cardiologist Bay Area Heart Center St.
More informationWill it heal? How to assess the probability of wound healing
Will it heal? How to assess the probability of wound healing Richard F. Neville, M.D. Professor of Surgery Chief, Division of Vascular Surgery George Washington University Limb center case 69 yr old male
More information- Lecture - Recommandations ESC : messages importants P. MEYER (Saint Laurent du Var) - Controverse - Qui doit faire l'angioplastie périphérique?
- Lecture - Recommandations ESC : messages importants P. MEYER (Saint Laurent du Var) - Controverse - Qui doit faire l'angioplastie périphérique? Un chirurgien E. DUCASSE (Bordeaux) Un interventionnel
More informationCRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS
CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS CRITICAL LIMB ISCHEMIA... 1 CONCLUSION... 9 U.S. CRITICAL LIMB ISCHEMIA PREVALENCE... 9 MARKET OPPORTUNITY ENDOVASCULAR... 9 MARKET OPPORTUNITY
More informationPeripheral Arterial Occlusive Disease- The Challenge in patients with diabetes
Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes Ashok Handa Reader in Surgery and Consultant Surgeon Nuffield Department of Surgery University of Oxford Introduction Vascular
More informationThe results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan
The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan COI disclosure Disclosure Speaker name: Taku Kato... I have the
More informationBe Still My Beating Heart!
030-Coronary Disease 1/13/04 12:21 PM Page 30 Be Still My Beating Heart! An Update on Coronary Disease Heart disease has long been considered a male health problem, because men are affected at an earlier
More information